Page last updated: 2024-12-08

1-testosterone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

There seems to be a misunderstanding. There is no compound known as 1-testosterone.

It is possible you are referring to **Testosterone**, which is the primary male sex hormone. However, there is no 1 prefix used in its name.

If you could provide more context or clarify what you are looking for, I might be able to help further. For example:

* Are you looking for information about the role of Testosterone in research?
* Are you looking for a specific compound related to Testosterone?
* Did you perhaps misspell the name of the compound?

Please provide more details so I can assist you accurately.

Delta(1)-dihydrotestosterone : An anabolic steroid that differs from testosterone by having a 1,2-double bond instead of a 4,5-double bond in its A ring. A potent androgen with anabolic properties, it was legally sold as a prohormone in the U.S.A. until 2005, when it was reclassified as a Schedule III drug. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID236666
CHEBI ID59714
SCHEMBL ID867595
MeSH IDM0510248

Synonyms (35)

Synonym
nsc-121140
nsc121140
65-06-5
5.alpha.-androst-1-en-3-one, 17.beta.-hydroxy-
nsc-39366
nsc39366
17beta-hydroxy-5alpha-androst-1-en-3-one
1-testo
androstendolone
delta1-dihydrotestosterone
DB01481
1-testosterone
1-t
5alpha-androst-1-en-17beta-ol-3-one
(5alpha,17beta)-hydroxyandrost-1-en-3-one
CHEBI:59714
delta(1)-dihydrotestosterone
(5s,8r,9s,10r,13s,14s,17s)-17-hydroxy-10,13-dimethyl-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
nsc 121140
1-(5beta)-androstene-17beta-ol-3-one
1-androstene-17-ol-3-one
unii-y984bv1q0g
y984bv1q0g ,
nsc 39366
1-t [steroid]
j108.132b ,
1-testosterone [mart.]
17.beta.-hydroxy-5.alpha.-androst-1-en-3-one
SCHEMBL867595
LMST02020110
OKJCFMUGMSVJBG-ABEVXSGRSA-N
DTXSID80215312
h_117_1_testosterone
Q4545805
?1-testosterone

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Herein, the designer steroid methyl-1-testosterone (M1T) (17β-hydroxy-17α-methyl-5α-androst-1-en-3-one) was identified, and its biological activity, potential adverse effects, and metabolism were investigated."( Endocrine characterization of the designer steroid methyl-1-testosterone: investigations on tissue-specific anabolic-androgenic potency, side effects, and metabolism.
Blatt, C; Diel, P; Fusshöller, G; Gütschow, M; Hess, C; Opfermann, G; Parr, MK; Schänzer, W; Zierau, O, 2011
)
0.89
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
anabolic agentA compound which stimulates anabolism and inhibits catabolism. Anabolic agents stimulate the development of muscle mass, strength, and power.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
anabolic androgenic steroidA steroid hormone related to the hormone testosterone. It increases protein synthesis within cells, which results in the buildup of cellular tissue (anabolism), especially in muscles. It also has androgenic and virilizing properties.
17beta-hydroxy steroidA 17-hydroxy steroid in which the hydroxy group at position 17 has a beta-configuration.
3-oxo-Delta(1) steroidAny 3-oxo steroid that contains a double bond between positions 1 and 2.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (30.00)18.7374
1990's0 (0.00)18.2507
2000's2 (20.00)29.6817
2010's5 (50.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 62.11

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index62.11 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.70 (4.65)
Search Engine Demand Index108.34 (26.88)
Search Engine Supply Index2.21 (0.95)

This Compound (62.11)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]